Earnings Feed
Start Free
|4Mar 7, 4:46 PM ET

CROWLEY Richard 4

4 · SAVIENT PHARMACEUTICALS INC · Filed Mar 7, 2013

Insider Transaction Report

Form 4
Period: 2013-03-05
SAVIENT PHARMACEUTICALS INCSVNT
CROWLEY Richard
EVP Biopharmaceutical Operatio
Transactions
  • Award

    Option to Purchase Common Stock

    2013-03-05+110,000→ 110,000 total
    Exercise: $0.94Exp: 2023-03-05→ Common Stock (110,000 underlying)
  • Award

    Option to Purchase Common Stock

    2013-03-05+100,000→ 100,000 total
    Exercise: $2.26Exp: 2022-02-01→ Common Stock (100,000 underlying)
  • Award

    Option to Purchase Common Stock

    2012-03-05+25,000→ 25,000 total
    Exercise: $11.62Exp: 2021-04-30→ Common Stock (25,000 underlying)
Footnotes (3)
  • [F1]These options will vest in proportional 25% increments on each of the first four anniversaries of the grant date, March 5, 2013.
  • [F2]These options reflect the vesting of performance options that were granted to the reporting person effective February 1, 2012.
  • [F3]These options reflect the vesting of performance options that were granted to the reporting person effective April 30, 2011.

Documents

1 file
  • 4
    rrd373139.xmlPrimary

    CROWLEY FORM 4